MedTrace Logo

Duct Endoscopy in Assessing Cellular Atypia in the Breast Duct Fluid of Women With a Genetic Risk for Breast Cancer

NCT00082979 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2013-08-26

No results posted yet for this study

Summary

RATIONALE: Diagnostic procedures, such as breast duct endoscopy, may improve the ability to detect breast cancer earlier and plan more effective treatment.

PURPOSE: This phase II trial is studying how well breast duct endoscopy works in assessing cellular atypia (abnormal cells) in the breast ducts of women with a genetic risk for breast cancer.

Conditions

Interventions

GENETIC

cytogenetic analysis

GENETIC

proteomic profiling

OTHER

cytology specimen collection procedure

OTHER

immunohistochemistry staining method

OTHER

laboratory biomarker analysis

PROCEDURE

breast duct lavage

Sponsors & Collaborators

  • Royal Marsden NHS Foundation Trust

    lead OTHER

Principal Investigators

  • Gerald Gui, MD, MS, FRCS(Edin), FRCS(Eng) · Royal Marsden NHS Foundation Trust

Study Design

Purpose
DIAGNOSTIC

Eligibility

Min Age
18 Years
Max Age
64 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-10-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00082979 on ClinicalTrials.gov